Stock Events

Stock Events

Roche 

0
2357
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 2026
€10.82
Mar 2025
€10.14
Mar 2024
€9.95
Mar 2023
€9.54
Mar 2022
€9.04
10Y Growth
3.88%
5Y Growth
5.54%
3Y Growth
4.28%
1Y Growth
6.62%

Earnings

Jan 28Expected
Q4 2025
Q2 2026
Next
8.83
9.82
10.81
11.8
Expected EPS
10.451946641891041
Actual EPS
N/A

Financials

20.93%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
65.95BRevenue
13.81BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RHO5.STU. It's not an investment recommendation.
Microsoft
199
MSFT
NVIDIA
159
NVDA
Alphabet
158
GOOGL
Coca-Cola
152
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap268B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap158.45B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck
MRK
Mkt Cap356.01B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap217.9B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap95.65B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

ROCHE HOLDING LTD ORD
Show More
CEO
Thomas Schinecker
Employees
103249
Country
Switzerland
ISIN
CH0012032048
WKN
000855167

Listings

MI
IT
1ROG.MI
MI
IT
1RO.MI
XETRA
DE
RHO.XETRA
F
DE
RHOA.F

0 Comments

Share your thoughts

FAQs

What is Roche stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Roche stocks are traded under the ticker RHO5.STU.
When is the next Roche earnings date?▼
Roche is going to release the next earnings report on January 28, 2027.
What were Roche earnings last quarter?▼
RHO5.STU earnings for the last quarter are 11.8 EUR per share, whereas the estimation was 10.99 EUR resulting in a +7.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Roche revenue for the last year?▼
Roche revenue for the last year amounts to 65.95B EUR.
What is Roche net income for the last year?▼
RHO5.STU net income for the last year is 13.81B EUR.
Does Roche pay dividends?▼
Yes, RHO5.STU dividends are paid annual. The last dividend per share was 10.82 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Roche have?▼
As of October 31, 2026, the company has 103,249 employees.
In which sector is Roche located?▼
Roche operates in the Health & Wellness sector.
When did Roche complete a stock split?▼
Roche has not had any recent stock splits.
Where is Roche headquartered?▼
Roche is headquartered in Basel, Switzerland.